These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8573939)
1. Nail pigmentation due to roxithromycin. Dawn G; Kanwar AJ; Dhar S Dermatology; 1995; 191(4):342-3. PubMed ID: 8573939 [No Abstract] [Full Text] [Related]
2. Onycholysis: an unusual side effect of roxithromycin. Sharma NL; Mahajan VK Indian J Dermatol Venereol Leprol; 2005; 71(1):49-50. PubMed ID: 16394366 [No Abstract] [Full Text] [Related]
3. [Is it caused by the medication? Sweet syndrome]. Thalmann H; Müller S; Müller JB MMW Fortschr Med; 2013 Jun; 155(12):5, 53. PubMed ID: 23923292 [No Abstract] [Full Text] [Related]
6. Nail pigmentation caused by hydroxyurea: report of 9 cases. Aste N; Fumo G; Contu F; Aste N; Biggio P J Am Acad Dermatol; 2002 Jul; 47(1):146-7. PubMed ID: 12077597 [TBL] [Abstract][Full Text] [Related]
7. Economic analysis of treatment with roxithromycin in comparison with erythromycin in patients with lower respiratory tract infections. Norinder A; Paulsen O; Hjortsberg C Scand J Infect Dis; 1997; 29(1):83-6. PubMed ID: 9112304 [TBL] [Abstract][Full Text] [Related]
8. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial. Hopstaken RM; Nelemans P; Stobberingh EE; Muris JW; Rinkens PE; Dinant GJ J Fam Pract; 2002 Apr; 51(4):329-36. PubMed ID: 11978255 [TBL] [Abstract][Full Text] [Related]
9. The acceptability, efficacy and safety of a new paediatric oral suspension of roxithromycin in respiratory tract infections. Moniot-Ville N; Chelly M; Consten L; Rosenbaum M J Int Med Res; 1998; 26(3):144-51. PubMed ID: 9718469 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerance of roxithromycin in comparison with erythromycin stearate in patients with lower respiratory tract infections. Paulsen O; Christensson BA; Hebelka M; Ljungberg B; Nilsson-Ehle I; Nyman L; Svensson R; Tüll P; Varga Z Scand J Infect Dis; 1992; 24(2):219-25. PubMed ID: 1641600 [TBL] [Abstract][Full Text] [Related]
11. Nail pigmentation due to hydroxycarbamide. Ceulen RP; Frank J; Poblete-Gutiérrez P Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal, transverse, and diffuse nail hyperpigmentation induced by hydroxyurea. Hernández-Martín A; Ros-Forteza S; de Unamuno P J Am Acad Dermatol; 1999 Aug; 41(2 Pt 2):333-4. PubMed ID: 10426924 [TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide-induced nail discoloration and skin hyperpigmentation: a rare presentation. Chittari K; Tagboto S; Tan BB Clin Exp Dermatol; 2009 Apr; 34(3):405-6. PubMed ID: 18627381 [No Abstract] [Full Text] [Related]
15. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis. Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576 [No Abstract] [Full Text] [Related]
16. [Treatment of acute and bacterial lower respiratory tract infections with roxithromycin]. Chabbou A; Belalgia S; Kamel A; Megdiche L Tunis Med; 1992 Oct; 70(10):467-71. PubMed ID: 1295159 [No Abstract] [Full Text] [Related]